FDA approves Exxua for depression treatment after multiple rejections over more than two decades  ...Middle East

The U.S. Food and Drug Administration (FDA) on Thursday approved the medication Exxua to treat major depressive disorder – a significant step after a decades-long battle for approval.  Exxua is unique for its ability to target the serotonin 1A receptor, which is a regulator of mood and emotion. In doing so, it avoids undesirable side effects that often come with drugs that treat anxiety and depression disorders, including sexual dysfunction and weight gain, according to the press release from drug manufacturer Fabre-Kramer Pharmaceuticals.  Fabre-Kramer described Exxua as inaugurating a “new class of antidepressant” that will be available in pharmacies in 2024.  "EXXUA represents

Hence then, the article about fda approves exxua for depression treatment after multiple rejections over more than two decades was published today ( Friday 29/09/2023 - 05:32 AM ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA approves Exxua for depression treatment after multiple rejections over more than two decades  )

Also on site :

• Denver Fire Department responds to 3-alarm fire at intersection of Leetsdale Drive and S. Forest Street
• Trial to begin for police officer charged in delayed response to Uvalde school shooting
• FDA Clears BrainSpace Intellidrop, an automated neuro device that addresses ICU nursing shortages and builds training data for Physical AI